FedEx Indicted For Illegally Distributing Drugs After 9-Year FDA/DEA Probe
This article was originally published in The Pink Sheet Daily
Executive Summary
Prosecutors allege FedEx ignored warnings from DEA, FDA and Congress and instead altered its practices to protect revenue from illegal online pharmacies.
You may also be interested in...
Illegal Internet Pharmacy “Enablers” To Be Subject Of House Hearings
The House Energy & Commerce Committee expects to hold hearings early next year on the role of credit card companies and shipping services in enabling illegal Internet pharmacies
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.
Current Pathways For Rare Disease Drugs Are Not Optimal, US FDA’s Califf Says
Anticipating a ‘tsunami of therapies’ for rare diseases, commissioner says the agency will have to think of creative approaches and employ regulatory flexibility for them. FDA considers copying the oncology center’s Project Facilitate for expanded access to other diseases.